ARTICLE | Clinical News
Ceprotin regulatory update
April 2, 2007 7:00 AM UTC
FDA approved Ceprotin human protein C concentrate to treat severe congenital protein C deficiency. The human protein C product, which has Orphan Drug status in the U.S., was approved in Europe in 2001...